Safety, Efficacy and Psychological Effects of Treating Antiretroviral Drug-Induced Facial Lipoatrophy With Bio-Alcamid

Clinical trial NCT00333684 · COMPLETED

Trial details

NCT number: NCT00333684
Sponsor: Canadian Immunodeficiency Research Collaborative
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Human Immunodeficiency Virus Facial Lipoatrophy

Start date: 2004-12-01
Primary completion: 2006-11-01
Enrollment: 36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.